Le Lézard
Classified in: Health
Subjects: TDS, TRI, FVT

NovoPath, Inc. Announces Benefactor Sponsorship for the Lab Executive War College Conference


PRINCETON, N.J., Feb. 21, 2018 /PRNewswire/ -- NovoPath, Inc., makers of the NovoPathtm Laboratory Information System Software, announces that it will be a Benefactor Sponsor of the 23rd annual Executive War College (EWC) Conference on Laboratory and Pathology Management. The EWC, the nation's pre-eminent gathering of lab leaders and innovators, will be held between April 30 and May 2, 2018 in New Orleans. In addition to meeting and exchanging ideas with thought leaders and laboratory industry experts, NovoPath will host an informative session on how laboratories can use LEAN principles.  This informative session will take place on Tuesday May 1, 2018.

"We are pleased to continue our sponsorship of the Executive War College and we hope that our prospects and our clients will have an opportunity to engage with us and exchange ideas on how to better serve the diagnostics market and ultimately the patient," said Rick Callahan, Vice President of Sales and Marketing for NovoPath. "The educational session NovoPath is sponsoring promises to provide timely and valuable information on how to better manage lab processes to increase productivity and improve patient safety."

"Both healthcare and laboratory medicine are changing at an accelerating rate," stated Robert L. Michel, Founder and Organizer of the Executive War College. "This makes it essential to have innovative companies like NovoPath participate and share the best practices in lab management and operations used by their most progressive lab clients. Contributions like NovoPath's are a key reason why the Executive War College is now the largest international conference on lab and pathology management."

NovoPath continues to partner with lab industry leaders in the healthcare sector to succeed in the ever-changing laboratory environment.

To experience the benefits of NovoPath firsthand, visit www.NovoPath.com and request a complimentary demonstration. To learn more about the EWC, visit www.executivewarcollege.com

About NovoPath

NovoPath, Inc. is a leading U.S.-based Lab Information Systems (LIS) company with over 24 years of experience in serving the Anatomic, Clinical and Molecular Pathology, Genetic Testing and Clinical Trials marketplaces.  NovoPath's clients range from national and regional reference labs to University and Teaching Hospitals, Regional and Community Hospitals and Specialty Labs.  NovoPath's mission is to provide unique and unparalleled solutions and services to all aspects of the Diagnostic Laboratory sector in a way that improves workflow, reduces the probability of human error, ensures results accuracy for greater patient safety, protects patient confidentiality, and above all, produces more precise and informative diagnostic outcomes.

Media Contact:
Rick Callahan
[email protected]
732.329.3209

SOURCE NovoPath, Inc.


These press releases may also interest you

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...

at 17:21
Chemistree Technology Inc. (US OTC: CHMJF) (the "Company" or "Chemistree"), is pleased to announce that the adjourned extraordinary meeting of the holders of the 10% senior unsecured convertible debentures of the Company (the "Debentures") was...

at 17:15
Summary Product: Counterfeit Viagra, 100 mg sildenafil tabletsIssue: Health products - Product safety, Unauthorized productWhat to do: Immediately stop using and safely dispose of this product. Consult your health care provider if you have taken this...



News published on and distributed by: